Novel effector protein functions encoded by T3SS positive V. cholerae

T3SS 阳性霍乱弧菌编码的新效应蛋白功能

基本信息

  • 批准号:
    10199931
  • 负责人:
  • 金额:
    $ 43.72万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-07-14 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Project Summary Vibrio cholerae causes the severe diarrheal disease cholera that is endemic in much of Asia, Africa, and South America, and has recently been reintroduced into Haiti. The species is highly diverse, although only O1 or O139 serogroup strains cause epidemic disease. However, increasing sporadic disease has been reported in endemic areas, and is caused by strains belonging to non-O1/non-O139 serogroups that present a public health threat both in developed and industrialized nations, including the United States. Unlike pathogenic O1 and O139 strains, the vast majority of pathogenic non-O1/non-O139 strains do not carry the well characterized virulence factors for colonization (TCP) and toxin production (CT), and the virulence mechanisms used by these strains are not well understood. Our study of pathogenic non-O1/non-O139 serogroup strains began with genomic sequencing of the clinically isolated O39 serogroup strain, AM-19226, which revealed a Type Three Secretion System (T3SS) that is conserved among other V. cholerae isolates. Our subsequent experiments identified 13 effector proteins that are translocated into the eukaryotic cell by the T3SS apparatus, and two transcriptional regulators encoded within the T3SS genomic island. We hypothesize that a subset of effectors and a T3SS encoded non-effector protein play important roles in colonization, and that other, unique V. cholerae effectors cooperate to disrupt host cell signaling to result in the diarrheal response that arises from cell-cell junction disruption, ionic transport imbalance and/or cellular stress responses. We propose to use complimentary in vitro and in vivo approaches to identify and characterize the mechanism of colonization and the host cell proteins and pathways targeted by V. cholerae effector proteins. Initial studies will define the minimum set of T3SS encoded genes necessary for colonization and define their roles in adherence to host cells. Effector protein analysis will focus on a total of five proteins and their roles in different stages of infection/disease: VopZZ, VopX, VopM, VopF, and VopK. VopZZ and VopM are critical for colonization, and Vops F and M have functions associated with cytoskeletal remodeling, which will be investigated in our studies. VopsX and K are unique to the V. cholerae T3SS, VopsX and K. We will use our experience the S. cerevisiae model system to discover host cell proteins that are the targets of effector activity and direct our studies in mammalian cells. We will also examine the host cell response to AM-19226 infection in vitro using mammalian co-culture and expression models. The co-culture assay will be used as a tool to dissect how effectors interact with mammalian signal transduction pathways during infection to disrupt homeostasis, whereas a viral-based expression system will be used to biochemically identify targets of effector protein activity and the response of mammalian cells to effector expression. We expect our results to reveal the molecular mechanisms of TCP/CT independent pathogenesis in the subset of non-O1/non-O139 strains that encode a T3SS.
项目摘要 霍乱弧菌导致严重腹泻病霍乱,在亚洲、非洲和南部大部分地区流行 美国,最近被重新引入海地。该物种是高度多样化的,虽然只有O 1或 O 139血清群菌株引起流行性疾病。然而,据报道, 流行区,由属于非O 1/非O 139血清群的菌株引起, 健康威胁在发达国家和工业化国家,包括美国。与致病性O 1不同 和O 139菌株,绝大多数致病性非O 1/非O 139菌株不携带良好表征的 定殖毒力因子(TCP)和毒素产生(CT),以及 这些菌株还没有被很好地理解。我们对致病性非O 1/非O 139血清群菌株的研究开始于 对临床分离的O39血清群菌株AM-19226进行基因组测序, 三个分泌系统(T3 SS)是其他霍乱弧菌分离株中保守的。我们随后 实验鉴定了通过T3 SS装置易位到真核细胞中的13种效应蛋白, 和T3 SS基因组岛内编码的两个转录调节因子。我们假设, 效应子和T3 SS编码的非效应子蛋白在定殖中起重要作用,而另一个,独特的 诉胆固醇效应物协同破坏宿主细胞信号传导,导致由以下引起的肠道反应: 细胞-细胞连接破坏、离子转运不平衡和/或细胞应激反应。我们建议使用 互补的体外和体内方法来识别和表征定植机制, 霍乱弧菌效应蛋白靶向的宿主细胞蛋白和途径。初步研究将确定 最小的一组T3 SS编码的基因必需的殖民和定义他们的作用,坚持主机 细胞效应蛋白分析将集中在总共五种蛋白质及其在不同阶段的作用。 感染/疾病:VopZZ、VopX、VopM、VopF和VopK。VopZZ和VopM对殖民至关重要, Vops F和M具有与细胞骨架重塑相关的功能,这将在我们的研究中进行研究。 VopsX和K是霍乱弧菌T3 SS、VopsX和K所特有的。我们将利用我们的经验,S。酿酒酵母 模型系统,以发现宿主细胞蛋白质是效应活性的目标,并指导我们的研究, 哺乳动物细胞我们还将使用哺乳动物细胞在体外检查宿主细胞对AM-19226感染的应答。 共培养和表达模式。共培养试验将用作剖析效应物如何相互作用的工具。 与哺乳动物的信号转导途径在感染破坏稳态,而基于病毒的 表达系统将用于生物化学鉴定效应蛋白活性的靶点和 哺乳动物细胞的效应表达。我们希望我们的研究结果能够揭示TCP/CT的分子机制 在编码T3 SS的非O 1/非O 139菌株亚群中的独立发病机制。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHELLE DZIEJMAN其他文献

MICHELLE DZIEJMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHELLE DZIEJMAN', 18)}}的其他基金

Rewiring networks for a pathogenic lifestyle
重新连接网络以适应致病的生活方式
  • 批准号:
    10893669
  • 财政年份:
    2023
  • 资助金额:
    $ 43.72万
  • 项目类别:
Pathogenic mechanisms of non-01/non-0139 V. cholerae
非01/非0139霍乱弧菌的致病机制
  • 批准号:
    8287501
  • 财政年份:
    2008
  • 资助金额:
    $ 43.72万
  • 项目类别:
Pathogenic mechanisms of non-01/non-0139 V. cholerae
非01/非0139霍乱弧菌的致病机制
  • 批准号:
    8067084
  • 财政年份:
    2008
  • 资助金额:
    $ 43.72万
  • 项目类别:
Pathogenic mechanisms of non-01/non-0139 V. cholerae
非01/非0139霍乱弧菌的致病机制
  • 批准号:
    7525518
  • 财政年份:
    2008
  • 资助金额:
    $ 43.72万
  • 项目类别:
Pathogenic mechanisms of non-01/non-0139 V. cholerae
非01/非0139霍乱弧菌的致病机制
  • 批准号:
    7631195
  • 财政年份:
    2008
  • 资助金额:
    $ 43.72万
  • 项目类别:
Pathogenic mechanisms of non-01/non-0139 V. cholerae
非01/非0139霍乱弧菌的致病机制
  • 批准号:
    7848314
  • 财政年份:
    2008
  • 资助金额:
    $ 43.72万
  • 项目类别:
MCP-4 AND LEUKOCYTE TRAFFICKING AND ACTIVATION
MCP-4 与白细胞运输和激活
  • 批准号:
    2667662
  • 财政年份:
    1998
  • 资助金额:
    $ 43.72万
  • 项目类别:
MCP-4 AND LEUKOCYTE TRAFFICKING AND ACTIVATION
MCP-4 与白细胞运输和激活
  • 批准号:
    2002982
  • 财政年份:
    1997
  • 资助金额:
    $ 43.72万
  • 项目类别:

相似海外基金

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 43.72万
  • 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
  • 批准号:
    10738120
  • 财政年份:
    2023
  • 资助金额:
    $ 43.72万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10526768
  • 财政年份:
    2022
  • 资助金额:
    $ 43.72万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10701072
  • 财政年份:
    2022
  • 资助金额:
    $ 43.72万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10679092
  • 财政年份:
    2021
  • 资助金额:
    $ 43.72万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10432133
  • 财政年份:
    2021
  • 资助金额:
    $ 43.72万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10327065
  • 财政年份:
    2021
  • 资助金额:
    $ 43.72万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10377366
  • 财政年份:
    2019
  • 资助金额:
    $ 43.72万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10574496
  • 财政年份:
    2019
  • 资助金额:
    $ 43.72万
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    $ 43.72万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了